Sanofi Blocks Launch Of Dr. Reddy's Generic Allegra-D 24 Hour; 20 Suits Are Pending Over Other Formulations

Over the past decade Sanofi-Aventis has filed more than 20 suits seeking to ward off generic competition for its Allegra franchise. It won a major victory on June 14 when a court granted a preliminary injunction to prevent Dr. Reddy's from launching a generic version of Allegra-D 24 Hour (fexofenadine 180 mg/pseudoephedrine 240 mg)